These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 5382327)
1. [The effect of antiplasmin on afibrinogenemia caused by the intravenous administration of Vipera lebeTINA VENOM]. Pastorova VE; Kikteva LK Biull Eksp Biol Med; 1969 Dec; 68(12):42-5. PubMed ID: 5382327 [No Abstract] [Full Text] [Related]
2. [The effect of antiplasmin on the course of experimental hypofibrinogenemia]. Pastorova VE; Kudriashov BA Biull Eksp Biol Med; 1967 Nov; 63(11):64-7. PubMed ID: 5633425 [No Abstract] [Full Text] [Related]
3. [Antifibrinolytic therapy in obstetrics and gynecology]. Schild W Gynaecologia; 1965; 160(1):39-48. PubMed ID: 5294537 [No Abstract] [Full Text] [Related]
4. [Treatment of congenital afibrinogenemia with antifibrinolytica]. Goldschmidt B Kinderarztl Prax; 1969 May; 37(5):203-8. PubMed ID: 5398350 [No Abstract] [Full Text] [Related]
5. [Effects of the injection of staphylocoagulase in rabbits. Attempt to prevent the defibrination syndrome]. Soulier JP; Prou-Wartelle O Nouv Rev Fr Hematol; 1967; 7(5):779-800. PubMed ID: 4230712 [No Abstract] [Full Text] [Related]
7. [Case contribution to the therapy of obstetrical afibrinogenemia]. Pleissner K Z Arztl Fortbild (Jena); 1967 Dec; 61(24):1297-9. PubMed ID: 5591403 [No Abstract] [Full Text] [Related]
8. [Fibrinopathy and blood transfusion]. Gueye SN; Pouye I; Mensah A; Dosseh B Bull Soc Med Afr Noire Lang Fr; 1973; 18(3):303-6. PubMed ID: 4784671 [No Abstract] [Full Text] [Related]
9. [Mechanism and treatment of fibrinopenia syndrome]. Cattan A Sem Ther; 1968 Feb; 44(2):92-4. PubMed ID: 5744013 [No Abstract] [Full Text] [Related]
10. The modification of experimental occlusive arterial thrombosis in the rat by Malayan pit viper venom. Chan KE Thromb Diath Haemorrh; 1968 Mar; 19(1):242-7. PubMed ID: 5652231 [No Abstract] [Full Text] [Related]
11. [Succinate dehydrogenase activity in the organs of white rats following poisoning with the venom of Vipera lebetina]. Puzik VI; Berdyeva AT; Diukanova MIa Biull Eksp Biol Med; 1970 Jan; 69(1):93-4. PubMed ID: 5430721 [No Abstract] [Full Text] [Related]
12. [Atom-absorption spectrometry in studying of Vipera lebetina obtusa venom]. Babaev ET; Abiev GA; Topchieva ShA; Chumburidze TB; Nemsitsveridze NG Georgian Med News; 2009 Sep; (174):98-100. PubMed ID: 19801744 [TBL] [Abstract][Full Text] [Related]
13. [Purification, characterization and evaluation of the thrombolytic activity of a fibrinogenase isolated from Vipera lebetina venom]. Gasmi A; Chabchoub A; Guermazi S; Karoui H; el Ayeb M; Dellagi K Arch Inst Pasteur Tunis; 1994; 71(3-4):483-6. PubMed ID: 8801849 [No Abstract] [Full Text] [Related]
15. [Properties of phosphodiesterase from Vipera lebetina venom immobilized on Agarose]. Zagrebel'nyĭ SN; Oreshkova SF Biokhimiia; 1981 Jul; 46(7):1277-82. PubMed ID: 6268196 [TBL] [Abstract][Full Text] [Related]
16. Cross-reactivities of polyclonal antibodies against lebetase, fibrinolytic enzyme of Levantine viper (Vipera lebetina) venom. Siigur J; Tõnismägi K; Tu AT; Siigur E Toxicon; 1996 May; 34(5):608-13. PubMed ID: 8783456 [TBL] [Abstract][Full Text] [Related]
17. [Blood coagulation activity of Vipera lebetina turanica venom and its neutralization by specific antiserum]. Roĭtman MI Vopr Med Khim; 1966; 12(5):477-83. PubMed ID: 6001045 [No Abstract] [Full Text] [Related]
18. [Has it yet been shown that certain acute fibrinopenias are due to massive intravascular coagulations?]. Amiel JL; Bernard JJ; Dormont J; Dreyfus B; Najean Y; Soulier JP Presse Med (1893); 1967 Sep; 75(40):1989-92. PubMed ID: 6061857 [No Abstract] [Full Text] [Related]
19. [Change in the content of nucleic acids in the tissues of mice under the influence of giurza (Vipera lebetina L.) venom and anti-giurza serum]. Meshalov AS Biull Eksp Biol Med; 1966 Aug; 62(8):36-9. PubMed ID: 6005472 [No Abstract] [Full Text] [Related]
20. Inefficacy of fresh frozen plasma in the treatment of L-asparaginase-induced coagulation factor deficiencies during ALL induction therapy. Nowak-Göttl U; Rath B; Binder M; Hassel JU; Wolff J; Husemann S; Ritter J Haematologica; 1995; 80(5):451-3. PubMed ID: 8566890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]